About ecSeq

Our strength is our people

Our bioinformatics team consists of research professionals with solid expertise in the analysis of high-throughput sequencing data. We are actively taking part in fundamental research topics, with ongoing publications in high-impact journals. Our research software engineers have up-to-date knowledge in developing high performance algorithms for deep sequencing experiments and using these to analyze the data.

The name reflects the aim

ecSeq [ˈi:zi]-[si:k]

Our company's name is pronounced as 'easy seek' and stands for 'engineering and consulting for Next-Generation Sequencing'.

David Langenberger
Chief Executive Officer
& Co-Founder

Dr. David Langenberger studied bioinformatics in Munich, New York, and Palo Alto, earning his PhD from the University of Leipzig in 2013. His work focuses on next-generation sequencing (NGS) data analysis and developing software tools to simplify bioinformatics workflows.

He has authored over 35 peer-reviewed papers in top journals like Nature Genetics and PNAS, covering topics from RNA-seq to bisulfite sequencing, with an emphasis on improving NGS data reproducibility and accuracy.

In 2012, David co-founded ecSeq Bioinformatics. Under his leadership, ecSeq has become a trusted partner for pharmaceutical companies, biotech firms, and academic institutions, offering tailored bioinformatics consulting, innovative software solutions, and renowned training programs.

Mario Fasold
Chief Technology Officer
& Co-Founder

Dr. Mario Fasold studied Bioinformatics and Mathematics in Jena, Umeå and Leipzig. In 2013 he received his doctorate in Bioinformatics from Leipzig University. His research was mainly focused on the assessment and improvement of the analysis methods of high-throughput technologies such as DNA microarrays and massively parallel sequencing.

He developed several software tools and contributed to over 15 research papers that were published in journals like Nature Biotechnology, Nucleic Acids Research and BMC Genomics. In 2012 he co-founded the company ecSeq Bioinformatics with the mission to improve and facilitate the analysis of sequencing data.

Gero Doose
Head of
Research and Development

Dr. Gero Doose holds a Master of Science in Bioinformatics from LMU and TU Munich, and earned his doctorate (Dr. rer. nat.) in Informatics from Leipzig University. As a scientist and software engineer, he specializes in developing advanced algorithms for genome informatics.

With a distinguished scientific career and over 25 research papers published in renowned journals such as Nature Genetics and PNAS, Dr. Doose has contributed significantly to international projects like the ICGC. His expertise includes creating sophisticated algorithms for RNA folding, protein solubility prediction, and differential alternative splicing detection.

At ecSeq Bioinformatics, Dr. Doose is a key member of the core development team for SeamlessNGS, an innovative genetic testing software that simplifies access to advanced bioinformatics protocols. This platform is designed to detect SNVs, InDels, Copy Number Variants, and RNA Fusions in clinical settings. Additionally, he is involved in custom NGS software development and various R&D initiatives across the company.

Adele Feuerstein
Head of
Marketing and Communication

Adele Feuerstein studied business administration with the focus on international management and social media marketing at the University Mittweida. She then spent half a year at Bosch's project management in Brno, Czech Republic until she joined the team of ecSeq Bioinformatics GmbH.